본문 바로가기
KERD
논문KCI 등재

An algorithm to predict the need for invasive mechanical ventilation in hospitalized COVID-19 patients: the experience in Sao Paulo

Osawa Eduardo Atsushi|Maciel Alexandre Toledo
대한중환자의학회 (The Korean Society Of Critical Care Medicine)|2022.11|Acute and Critical Care|제37권 제4호|pp. 580-591|DOI 10.4266/acc.2022.00283

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

COVID-19coronavirusalgorithmintensive care unitsmechanical ventilationSARS-CoV-2.

초록

Background: We aimed to characterize patients hospitalized for coronavirus disease 2019 (COVID-19) and identify predictors of invasive mechanical ventilation (IMV). Methods: We performed a retrospective cohort study in patients with COVID-19 admitted to a private network in Sao Paulo, Brazil from March to October 2020. Patients were compared in three subgroups: non-intensive care unit (ICU) admission (group A), ICU admission without receiving IMV (group B) and IMV requirement (group C). We developed logistic regression algorithm to identify predictors of IMV. Results: We analyzed 1,650 patients, the median age was 53 years (range, 42–65) and 986 patients (59.8%) were male. The median duration from symptom onset to hospital admission was 7 days (5–9) and the main comorbidities were hypertension (42.4%), diabetes (24.2%) and obesity (15.8%). We found differences among subgroups in laboratory values obtained at hospital admission. The predictors of IMV (odds ratio and 95% confidence interval [CI]) were male (1.81 [1.11–2.94], P=0.018), age (1.03 [1.02–1.05], P<0.001), obesity (2.56 [1.57–4.15], P<0.001), duration from symptom onset to admission (0.91 [0.85–0.98], P=0.011), arterial oxygen saturation (0.95 [0.92–0.99], P=0.012), C-reactive protein (1.005 [1.002–1.008], P<0.001), neutrophil-to-lymphocyte ratio (1.046 [1.005–1.089], P=0.029) and lactate dehydrogenase (1.005 [1.003–1.007], P<0.001). The area under the curve values were 0.860 (95% CI, 0.829–0.892) in the development cohort and 0.801 (95% CI, 0.733–0.870) in the validation cohort.Conclusions: Patients had distinct clinical and laboratory parameters early in hospital admission. Our prediction model may enable focused care in patients at high risk of IMV.

Abstract

Background: We aimed to characterize patients hospitalized for coronavirus disease 2019 (COVID-19) and identify predictors of invasive mechanical ventilation (IMV). Methods: We performed a retrospective cohort study in patients with COVID-19 admitted to a private network in Sao Paulo, Brazil from March to October 2020. Patients were compared in three subgroups: non-intensive care unit (ICU) admission (group A), ICU admission without receiving IMV (group B) and IMV requirement (group C). We developed logistic regression algorithm to identify predictors of IMV. Results: We analyzed 1,650 patients, the median age was 53 years (range, 42–65) and 986 patients (59.8%) were male. The median duration from symptom onset to hospital admission was 7 days (5–9) and the main comorbidities were hypertension (42.4%), diabetes (24.2%) and obesity (15.8%). We found differences among subgroups in laboratory values obtained at hospital admission. The predictors of IMV (odds ratio and 95% confidence interval [CI]) were male (1.81 [1.11–2.94], P=0.018), age (1.03 [1.02–1.05], P<0.001), obesity (2.56 [1.57–4.15], P<0.001), duration from symptom onset to admission (0.91 [0.85–0.98], P=0.011), arterial oxygen saturation (0.95 [0.92–0.99], P=0.012), C-reactive protein (1.005 [1.002–1.008], P<0.001), neutrophil-to-lymphocyte ratio (1.046 [1.005–1.089], P=0.029) and lactate dehydrogenase (1.005 [1.003–1.007], P<0.001). The area under the curve values were 0.860 (95% CI, 0.829–0.892) in the development cohort and 0.801 (95% CI, 0.733–0.870) in the validation cohort.Conclusions: Patients had distinct clinical and laboratory parameters early in hospital admission. Our prediction model may enable focused care in patients at high risk of IMV.

참고문헌 (43)

  1. Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
  2. Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
  3. Liu J, "Lymphopenia predicted illness severity and recovery in patients with COVID-19 : a single-center, retrospective study", PLoS One, 15, pp.e0241659~ (2020)
  4. Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China", N Engl J Med, 382, pp.1708~1720 (2020)
  5. Kiss S, "Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19 : a systematic review and meta-analysis", Med Microbiol Immunol, 210, pp.33~47 (2021)
  6. Wynants L, "Prediction models for diagnosis and prognosis of covid-19 : systematic review and critical appraisal", BMJ, 369, pp.m1328~ (2020)
  7. RECOVERY Collaborative Group, "Dexamethasone in hospitalized patients with COVID-19", N Engl J Med, 384, pp.693~704 (2021)
  8. Cavalcanti AB, "Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19", N Engl J Med, 383, pp.2041~2052 (2020)
  9. Ruan Q, "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China", Intensive Care Med, 46, pp.846~848 (2020)
  10. Chen W, "Plasma CRP level is positively associated with the severity of COVID-19", Ann Clin Microbiol Antimicrob, 19, pp.18~ (2020)
  11. Herold T, "Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19", J Allergy Clin Immunol, 146, pp.128~136 (2020)
  12. Luo X, "Prognostic value of C-reactive protein in patients with coronavirus 2019", Clin Infect Dis, 71, pp.2174~2179 (2020)
  13. Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
  14. Tan L, "Lymphopenia predicts disease severity of COVID-19 : a descriptive and predictive study", Signal Transduct Target Ther, 5, pp.33~ (2020)
  15. Wagner J, "Absolute lymphocyte count is a prognostic marker in COVID-19 : a retrospective cohort review", Int J Lab Hematol, 42, pp.761~765 (2020)
  16. Ziadi A, "Lymphopenia in critically ill COVID-19 patients : a predictor factor of severity and mortality", Int J Lab Hematol, 43, pp.e38~e40 (2021)
  17. Martha JW, "Prognostic value of elevated lactate dehydrogenase in patients with COVID-19 : a systematic review and meta-analysis", Postgrad Med J, 98, pp.422~427 (2022)
  18. Szarpak L, "Lactate dehydrogenase level as a COVID-19 severity marker", Am J Emerg Med, 45, pp.638~639 (2021)
  19. Chen XY, "Lactate dehydrogenase elevations is associated with severity of COVID-19 : a meta-analysis", Crit Care, 24, pp.459~ (2020)
  20. Mo P, "Clinical characteristics of refractory coronavirus disease 2019 in Wuhan, China", Clin Infect Dis, 73, pp.e4208~e4213 (2019)[DOI]
  21. Li T, "Baseline characteristics and changes of biomarkers in disease course predict prognosis of patients with COVID-19", Intern Emerg Med, 16, pp.1165~1172 (2021)
  22. Mueller AA, "Inflammatory biomarker trends predict respiratory decline in COVID-19 patients", Cell Rep Med, 1, pp.100144~ (2020)
  23. Smilowitz NR, "C-reactive protein and clinical outcomes in patients with COVID-19", Eur Heart J, 42, pp.2270~2279 (2021)
  24. Manson JJ, "COVID-19-associated hyperinflammation and escalation of patient care : a retrospective longitudinal cohort study", Lancet Rheumatol, 2, pp.e594~e602 (2020)
  25. Kohno S, "Prediction of requirement for mechanical ventilation in community-acquired pneumonia with acute respiratory failure : a multicenter prospective study", Respiration, 85, pp.27~35 (2013)
  26. Ferrer M, "Severe community-acquired pneumonia : characteristics and prognostic factors in ventilated and non-ventilated patients", PLoS One, 13, pp.e0191721~ (2018)
  27. Lim WS, "Defining community acquired pneumonia severity on presentation to hospital : an international derivation and validation study", Thorax, 58, pp.377~382 (2003)
  28. Fine MJ, "A prediction rule to identify low-risk patients with community-acquired pneumonia", N Engl J Med, 336, pp.243~250 (1997)
  29. Tian J, "Comparison of clinical characteristics between coronavirus disease 2019 pneumonia and community-acquired pneumonia", Curr Med Res Opin, 36, pp.1747~1752 (2020)
  30. Bain W, "COVID-19 versus non-COVID-19 acute respiratory distress syndrome : comparison of demographics, physiologic parameters, inflammatory biomarkers, and clinical outcomes", Ann Am Thorac Soc, 18, pp.1202~1210 (2021)
  31. Di Mitri C, "COVID-19 and non-COVID-19 pneumonia : a comparison", Ann Med, 53, pp.2321~2331 (2021)
  32. Wicky PH, "Ventilator-associated pneumonia in the era of COVID-19 pandemic : how common and what is the impact?", Crit Care, 25, pp.153~ (2021)
  33. Ji D, "Prediction for progression risk in patients with COVID-19 pneumonia : the CALL score", Clin Infect Dis, 71, pp.1393~1399 (2020)
  34. Fernandes FT, "A multipurpose machine learning approach to predict COVID-19 negative prognosis in São Paulo, Brazil", Sci Rep, 11, pp.3343~ (2021)
  35. Yu L, "Machine learning methods to predict mechanical ventilation and mortality in patients with COVID-19", PLoS One, 16, pp.e0249285~ (2021)
  36. Wu G, "Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission : an international multicentre study", Eur Respir J, 56, pp.2001104~ (2020)
  37. Heo J, "Prediction of patients requiring intensive care for COVID-19 : development and validation of an integer-based score using data from Centers for Disease Control and Prevention of South Korea", J Intensive Care, 9, pp.16~ (2021)
  38. Grasselli G, "Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy", JAMA Intern Med, 180, pp.1345~1355 (2020)
  39. Gupta S, "Factors associated with death in critically ill patients with coronavirus disease 2019 in the US", JAMA Intern Med, 180, pp.1436~1447 (2020)
  40. Song J, "Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea : a nationwide retrospective cohort study", Sci Rep, 11, pp.10066~ (2021)
  41. Park HY, "Presenting characteristics and clinical outcome of patients with COVID-19 in South Korea : a nationwide retrospective observational study", Lancet Reg Health West Pac, 5, pp.100061~ (2020)
  42. Bartoletti M, "Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-CoV-2 infection : a multicentre cohort study(PREDI-CO study)", Clin Microbiol Infect, 26, pp.1545~1553 (2020)
  43. Azoulay E, "Increased mortality in patients with severe SARS-CoV-2 infection admitted within seven days of disease onset", Intensive Care Med, 46, pp.1714~1722 (2020)

관련 논문AI추천

New Scoring System for Predicting Mortality in Patients with COVID-19권기태, 김신우, 김윤정, 배소현, 장현하, 황소윤연세대학교의과대학 · Yonsei Medical Journal2021 · 제62권 제9호Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?COVID-19 Team, Dilek Ernam, Elif Yıldırım, Eylem Tuncay, Ipek Ozmen, Meltem Agca, Nazlı Huma Teke, Nermin Ozer Yılmaz, Reyhan Yıldız, Simge Yavuz, Tülin Sevim, Zuhal Karakurt대한감염학회 · Infection and Chemotherapy2021 · 제53권 제2호Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patientsAli Haris, Arshad Ainan, Ayaz Ahmed, Hussain Erfan, Jamil Bushra, Malik Hajra대한중환자의학회 · Acute and Critical Care2020 · 제35권 제4호Utilization of C-Reactive Protein Test as a Predictor of Lung Injury in Patients with Coronavirus Disease 2019강웅래, 곽상규, 김경찬, 김상경, 김영환, 유은형, 전창호, 정치영, 홍효림대한진단검사의학회 · Laboratory Medicine Online2021 · 제11권 제2호Predictors of Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis김우림, 이경은, 한지민한국임상약학회 · 한국임상약학회지2020 · 제30권 제3호Validation of Machine Learning Models to Predict Adverse Outcomes in Patients with COVID-19: A Prospective Pilot Study김형준, 오홍상, 한덕재, 허준녕연세대학교의과대학 · Yonsei Medical Journal2022 · 제63권 제5호

이 간행물의 다른 논문 (29건)

Target temperature management in traumatic brain injury with a focus on adverse events, recognition, and prevention조광욱pp. 483-490Asynchronies during invasive mechanical ventilation: narrative review and updateGómez-González Alberto, Saavedra Santiago Nicolás, Barisich Patrick Valentino Sepúlveda, Maldonado José Benito Parra, Lumini Romina Belén, Gallardo Adriánpp. 491-501Lung ultrasound for evaluation of dyspnea: a pictorial reviewJuneja Monica, Dixit Rashmi, Prakash Anjali, Murali Aparna, Kumar Nareshpp. 502-515Barriers and facilitators in the provision of palliative care in adult intensive care units: a scoping reviewAmalia Sarah, Effendy Christantie, Yodang Yodang, Rochmawati Ernapp. 516-526Validation of presepsin measurement for mortality prediction of sepsis: a preliminary study최세홍, Baik Seungmin, 홍경숙, 박진, 김태윤pp. 527-532
원문 보기